Profile data is unavailable for this security.
About the company
Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL).
- Revenue in CAD (TTM)14.25m
- Net income in CAD-2.64m
- Incorporated2012
- Employees--
- LocationRelevium Technologies Inc1000 Sherbrooke St W Suite 2700MONTREAL H3A 3G4CanadaCAN
- Phone+1 (514) 824-8559
- Fax+1 (514) 824-8559
- Websitehttps://releviumtechnologies.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EastWest Bioscience Inc | 789.84k | 108.55k | 2.50m | -- | -- | -- | 23.99 | 3.17 | 0.0008 | 0.0008 | 0.008 | 0.0341 | 0.147 | 1.27 | 7.11 | -- | -0.0108 | -- | -0.0315 | -- | 66.74 | -- | -0.0734 | -- | 0.0281 | -3.13 | 0.4175 | -- | -19.03 | -- | -41.80 | -- | -- | -- |
ORAGIN Foods Inc | 23.25m | -3.17m | 3.14m | 125.00 | -- | -- | -- | 0.1352 | -0.0519 | -0.0519 | 0.3806 | 0.1873 | 0.9043 | 11.97 | 200.90 | 185,973.30 | -12.32 | -15.01 | -14.64 | -19.69 | 29.85 | 28.90 | -13.62 | -9.39 | 0.226 | -1.45 | 0.485 | -- | -15.08 | 40.76 | -1,034.28 | -- | 1.44 | -- |
Relevium Technologies Inc | 14.25m | -2.64m | 6.64m | -- | -- | -- | -- | 0.4663 | -0.0158 | -0.0158 | 0.052 | -0.0035 | 0.9457 | 153.67 | 13.51 | -- | -17.50 | -72.98 | -- | -132.33 | 17.32 | -- | -18.50 | -184.28 | 0.5856 | 1.74 | 4.40 | -- | -69.28 | -- | 22.55 | -- | -- | -- |
DavidsTea Inc | 60.64m | -13.83m | 7.85m | 159.00 | -- | 0.3683 | -- | 0.1295 | -0.5171 | -0.5171 | 2.27 | 0.8011 | 1.14 | 2.06 | 23.98 | -- | -26.01 | -8.47 | -39.58 | -16.75 | 40.18 | 44.74 | -22.80 | -6.66 | 1.25 | -- | 0.2874 | -- | -26.96 | -22.20 | 7.00 | -- | -23.58 | -- |